NCT01914939: A trial that was reported late by Massachusetts General Hospital
This trial has reported, although it was 1108 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01914939 |
|---|---|
| Title | A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 30, 2014 |
| Completion date | Nov. 30, 2017 |
| Required reporting date | Nov. 30, 2018, midnight |
| Actual reporting date | Dec. 12, 2021 |
| Date last checked at ClinicalTrials.gov | Nov. 14, 2025 |
| Days late | 1108 |